Buscar resultados de ensayos clínicos
Adenomyoepithelioma - 11 Studies Found
| Estado | Estudiar |
| Completed |
Nombre del estudio: Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer Condición:
|
| Completed |
Nombre del estudio: A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas Condición:
Fecha: 2012-06-19 Intervenciones: |
| Completed |
Nombre del estudio: Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer Condición:
|
| Completed |
Nombre del estudio: Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer Condición:
|
| Completed |
Nombre del estudio: High-dose Bevacizumab in Advanced Renal Carcinoma Patients Condición:
Fecha: 2007-04-03 Intervenciones: Drug: Bevacizumab Bevacizumab Other Name: Avastin |
| Terminated |
Nombre del estudio: A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers Condición: Uterine Cancer Fecha: 2005-09-30 Intervenciones: Drug: Celecoxib |
| Completed |
Nombre del estudio: Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer Condición: Endometrial Cancer Fecha: 1999-11-01 Intervenciones:
|
| Completed |
Nombre del estudio: Whole-Abdominal Radiation Therapy and Cisplatin in Treating Patients With Stage III or Stage IV Endometrial Cancer That Has Been Removed by Surgery Condición: Endometrial Cancer Fecha: 2007-03-15 Intervenciones:
|
| Completed |
Nombre del estudio: Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer Condición: Endometrial Cancer Fecha: 2000-05-02 Intervenciones:
|
| Completed |
Nombre del estudio: S9720 Combination Chemotherapy in Treating Patients With Metastatic, Recurrent, or Refractory Endometrial Cancer Condición: Endometrial Cancer Fecha: 1999-11-01 Intervenciones:
|